Central nervous system involvement in goats undergoing primary infections with Trypanosoma brucei and relapse infections after chemotherapy

Relapse of infection after trypanocidal drug treatment of trypanosome infections is normally attributed to drug resistance on the part of the parasite, under-dosage of the drug, or reinfection of the host. We have demonstrated relapse infections in goats arising from none of these. Fourteen goats in...

Full description

Bibliographic Details
Main Authors: Whitelaw, D.D., Moulton, J.E., Morrison, W. Ivan, Murray, M.
Format: Journal Article
Language:Inglés
Published: Cambridge University Press 1985
Subjects:
Online Access:https://hdl.handle.net/10568/29433
_version_ 1855517094035062784
author Whitelaw, D.D.
Moulton, J.E.
Morrison, W. Ivan
Murray, M.
author_browse Morrison, W. Ivan
Moulton, J.E.
Murray, M.
Whitelaw, D.D.
author_facet Whitelaw, D.D.
Moulton, J.E.
Morrison, W. Ivan
Murray, M.
author_sort Whitelaw, D.D.
collection Repository of Agricultural Research Outputs (CGSpace)
description Relapse of infection after trypanocidal drug treatment of trypanosome infections is normally attributed to drug resistance on the part of the parasite, under-dosage of the drug, or reinfection of the host. We have demonstrated relapse infections in goats arising from none of these. Fourteen goats infected withTrypanosoma bruceisuffered severe illness and 3 died within 45 days. Despite treatment with the trypanocidal drug Berenil, a 4th goat died 2 days later. Recovery of the remainder followed chemotherapy, and in 2 goats, necropsiecl 45 days after treatment, no trypanosomes or abnormalities were detected. However 2–3 months after Berenil chemotherapy, despite trypanosomes being undetectable in the blood during the intervening period, infections in 4 of the remaining 8 animals relapsed. At all stages of the primary and relapse infections, trypanosomes isolated from the blood of the goats were completely susceptible to Berenil when tested in mice, as were parasites isolated from cerebrospinal fluid and brain tissue at necropsy. At the time of treatment, only minimal cellular infiltration was found in the central nervous system (CNS), but death from the relapse infection was associated with a very severe meningoencephalitis. We conclude that the relapse infections were caused by the re-emergence of trypanosornes from the CNS, where sequestered parasites were inaccessible to the trypanocidal effects of the drug.
format Journal Article
id CGSpace29433
institution CGIAR Consortium
language Inglés
publishDate 1985
publishDateRange 1985
publishDateSort 1985
publisher Cambridge University Press
publisherStr Cambridge University Press
record_format dspace
spelling CGSpace294332024-11-15T08:52:11Z Central nervous system involvement in goats undergoing primary infections with Trypanosoma brucei and relapse infections after chemotherapy Whitelaw, D.D. Moulton, J.E. Morrison, W. Ivan Murray, M. infection nervous system trypanosoma brucei goats chemotherapy drug therapy disease control infectious diseases parasitology Relapse of infection after trypanocidal drug treatment of trypanosome infections is normally attributed to drug resistance on the part of the parasite, under-dosage of the drug, or reinfection of the host. We have demonstrated relapse infections in goats arising from none of these. Fourteen goats infected withTrypanosoma bruceisuffered severe illness and 3 died within 45 days. Despite treatment with the trypanocidal drug Berenil, a 4th goat died 2 days later. Recovery of the remainder followed chemotherapy, and in 2 goats, necropsiecl 45 days after treatment, no trypanosomes or abnormalities were detected. However 2–3 months after Berenil chemotherapy, despite trypanosomes being undetectable in the blood during the intervening period, infections in 4 of the remaining 8 animals relapsed. At all stages of the primary and relapse infections, trypanosomes isolated from the blood of the goats were completely susceptible to Berenil when tested in mice, as were parasites isolated from cerebrospinal fluid and brain tissue at necropsy. At the time of treatment, only minimal cellular infiltration was found in the central nervous system (CNS), but death from the relapse infection was associated with a very severe meningoencephalitis. We conclude that the relapse infections were caused by the re-emergence of trypanosornes from the CNS, where sequestered parasites were inaccessible to the trypanocidal effects of the drug. 1985-04 2013-06-11T09:23:33Z 2013-06-11T09:23:33Z Journal Article https://hdl.handle.net/10568/29433 en Limited Access Cambridge University Press Parasitology;90: 255-268
spellingShingle infection
nervous system
trypanosoma brucei
goats
chemotherapy
drug therapy
disease control
infectious diseases
parasitology
Whitelaw, D.D.
Moulton, J.E.
Morrison, W. Ivan
Murray, M.
Central nervous system involvement in goats undergoing primary infections with Trypanosoma brucei and relapse infections after chemotherapy
title Central nervous system involvement in goats undergoing primary infections with Trypanosoma brucei and relapse infections after chemotherapy
title_full Central nervous system involvement in goats undergoing primary infections with Trypanosoma brucei and relapse infections after chemotherapy
title_fullStr Central nervous system involvement in goats undergoing primary infections with Trypanosoma brucei and relapse infections after chemotherapy
title_full_unstemmed Central nervous system involvement in goats undergoing primary infections with Trypanosoma brucei and relapse infections after chemotherapy
title_short Central nervous system involvement in goats undergoing primary infections with Trypanosoma brucei and relapse infections after chemotherapy
title_sort central nervous system involvement in goats undergoing primary infections with trypanosoma brucei and relapse infections after chemotherapy
topic infection
nervous system
trypanosoma brucei
goats
chemotherapy
drug therapy
disease control
infectious diseases
parasitology
url https://hdl.handle.net/10568/29433
work_keys_str_mv AT whitelawdd centralnervoussysteminvolvementingoatsundergoingprimaryinfectionswithtrypanosomabruceiandrelapseinfectionsafterchemotherapy
AT moultonje centralnervoussysteminvolvementingoatsundergoingprimaryinfectionswithtrypanosomabruceiandrelapseinfectionsafterchemotherapy
AT morrisonwivan centralnervoussysteminvolvementingoatsundergoingprimaryinfectionswithtrypanosomabruceiandrelapseinfectionsafterchemotherapy
AT murraym centralnervoussysteminvolvementingoatsundergoingprimaryinfectionswithtrypanosomabruceiandrelapseinfectionsafterchemotherapy